A detailed history of Greenwood Capital Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 10,912 shares of LLY stock, worth $8.68 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
10,912
Previous 11,509 5.19%
Holding current value
$8.68 Million
Previous $10.4 Million 7.23%
% of portfolio
1.28%
Previous 1.4%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$772.14 - $960.02 $460,967 - $573,131
-597 Reduced 5.19%
10,912 $9.67 Million
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $461,017 - $578,149
-636 Reduced 5.24%
11,509 $10.4 Million
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $1.23 Million - $1.65 Million
-2,085 Reduced 14.65%
12,145 $9.45 Million
Q4 2023

Mar 05, 2024

SELL
$525.19 - $619.13 $209,550 - $247,032
-399 Reduced 2.73%
14,230 $8.29 Million
Q3 2023

Oct 18, 2023

SELL
$434.7 - $599.3 $985,030 - $1.36 Million
-2,266 Reduced 13.41%
14,629 $7.86 Million
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $1.62 Million - $2.17 Million
-4,632 Reduced 21.52%
16,895 $7.92 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $732,776 - $860,610
2,359 Added 12.31%
21,527 $7.39 Million
Q4 2022

Jan 26, 2023

SELL
$321.55 - $374.67 $408,690 - $476,205
-1,271 Reduced 6.22%
19,168 $0
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $98,431 - $112,172
-332 Reduced 1.6%
20,439 $6.61 Million
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $5.77 Million - $6.78 Million
20,710 Added 33950.82%
20,771 $6.73 Million
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $9.67 Million - $12 Million
-41,221 Reduced 99.85%
61 $17,000
Q4 2021

Feb 03, 2022

SELL
$224.85 - $279.04 $112,874 - $140,078
-502 Reduced 1.2%
41,282 $11.4 Million
Q3 2021

Oct 27, 2021

BUY
$221.6 - $272.71 $1.11 Million - $1.36 Million
4,991 Added 13.57%
41,784 $9.66 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $79,983 - $103,458
-443 Reduced 1.19%
36,793 $8.45 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $950,755 - $1.23 Million
-5,786 Reduced 13.45%
37,236 $6.96 Million
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $121,066 - $160,200
-928 Reduced 2.11%
43,022 $7.26 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $773,357 - $894,528
5,289 Added 13.68%
43,950 $6.51 Million
Q2 2020

Aug 12, 2020

SELL
$136.42 - $164.18 $1.27 Million - $1.53 Million
-9,291 Reduced 19.38%
38,661 $6.35 Million
Q1 2020

May 12, 2020

BUY
$119.05 - $147.35 $278,100 - $344,209
2,336 Added 5.12%
47,952 $6.65 Million
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $1.76 Million - $2.19 Million
16,507 Added 56.71%
45,616 $6 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $3.11 Million - $3.38 Million
29,109 New
29,109 $3.26 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.